UBS Group lowered shares of Cano Health (NYSE:CANO – Get Rating) from a buy rating to a neutral rating in a research note released on Friday morning, MarketBeat reports. They currently have $1.25 target price on the stock, down from their previous target price of $12.00.
Several other equities research analysts have also issued reports on CANO. Cowen lowered shares of Cano Health from an outperform rating to a market perform rating and lowered their price target for the company from $10.00 to $3.00 in a report on Thursday, November 10th. Raymond James downgraded shares of Cano Health from an outperform rating to a market perform rating in a research note on Thursday, November 10th. Wolfe Research downgraded shares of Cano Health from an outperform rating to a peer perform rating in a research note on Thursday, January 5th. Credit Suisse Group reduced their target price on shares of Cano Health to $4.00 in a research note on Monday, November 28th. Finally, Cowen downgraded shares of Cano Health from an outperform rating to a market perform rating and reduced their target price for the company from $10.00 to $3.00 in a research note on Thursday, November 10th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of Hold and an average target price of $4.08.
Get Cano Health alerts:Cano Health Trading Up 13.2 %
Shares of Cano Health stock opened at $1.20 on Friday. The firm has a market capitalization of $593.38 million, a PE ratio of -3.16 and a beta of 0.15. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.64 and a quick ratio of 1.64. The company's fifty day moving average price is $1.83 and its two-hundred day moving average price is $4.66. Cano Health has a 52-week low of $0.98 and a 52-week high of $9.75.
Cano Health (NYSE:CANO – Get Rating) last announced its quarterly earnings results on Wednesday, November 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. The firm had revenue of $665.03 million for the quarter, compared to analyst estimates of $712.06 million. Cano Health had a negative net margin of 2.28% and a negative return on equity of 4.50%. On average, analysts expect that Cano Health will post -0.22 EPS for the current year.Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in CANO. Raymond James & Associates lifted its position in Cano Health by 12.1% during the 1st quarter. Raymond James & Associates now owns 125,611 shares of the company's stock worth $798,000 after buying an additional 13,593 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Cano Health by 18.6% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 169,145 shares of the company's stock valued at $1,074,000 after purchasing an additional 26,550 shares during the period. Bank of New York Mellon Corp lifted its position in Cano Health by 19.2% during the 1st quarter. Bank of New York Mellon Corp now owns 78,241 shares of the company's stock valued at $497,000 after purchasing an additional 12,578 shares during the period. HighTower Advisors LLC acquired a new position in Cano Health during the 1st quarter valued at about $129,000. Finally, Allianz Asset Management GmbH acquired a new position in Cano Health during the 1st quarter valued at about $2,268,000. Institutional investors and hedge funds own 25.56% of the company's stock.
Cano Health Company Profile
(Get Rating)
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
Featured Articles
- Get a free copy of the StockNews.com research report on Cano Health (CANO)
- 3 Airline Stocks Taking Off in 2023
- Why Wall Street Has Bullish Targets on Target Stock
- What Macy's Guidance Means For Retail
- Fortinet Stock Price Bumpy, Here Is Why
- Apexigen Stock Soars After Analyst Rating, Is It Time to Buy?
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.